"The good news is that there is basically no value being placed on Oncology side of business where paradoxically this is where the real blue sky is"
This is not good news if you want to avoid dilution of your interest in the Oncology side of the business if/when the business is de-merged.
Add to My Watchlist
What is My Watchlist?